KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Receivables - Accured (2022)

Historic Receivables - Accured for Precigen (PGEN) over the last 1 years, with Q1 2022 value amounting to $18000.0.

  • Precigen's Revenue - Other rose 3308.64% to $539000.0 in Q2 2018 from the same period last year, while for Jun 2018 it was $1.5 million, marking a year-over-year decrease of 882.72%. This contributed to the annual value of $1.2 million for FY2017, which is 1469.47% up from last year.
  • Per Precigen's latest filing, its Receivables - Accured stood at $18000.0 for Q1 2022.
  • In the past 5 years, Precigen's Revenue - Other ranged from a high of $539000.0 in Q2 2018 and a low of $14000.0 during Q2 2014
  • Moreover, its 5-year median value for Revenue - Other was $257500.0 (2015), whereas its average is $272722.2.
  • In the last 5 years, Precigen's Revenue - Other skyrocketed by 130000.0% in 2014 and then crashed by 4965.03% in 2017.
  • Quarter analysis of 5 years shows Precigen's Revenue - Other stood at $280000.0 in 2014, then skyrocketed by 31.07% to $367000.0 in 2015, then fell by 27.79% to $265000.0 in 2016, then increased by 14.34% to $303000.0 in 2017, then skyrocketed by 77.89% to $539000.0 in 2018.
  • Its Revenue - Other was $539000.0 in Q2 2018, compared to $419000.0 in Q1 2018 and $303000.0 in Q4 2017.